Ethica Group’s M&A Advisory with Alessandro Conte, Roberto Liguori and Cristian Cingari, and by InterCapital, with Tim Lep, advised ANJAC on its acquisition of HCG (Health Chain Group).
The two member firms worked in close coordination, leveraging strong relationships and seamless communication, and offering a compelling example of Mergers Alliance’s collaborative culture and commitment to shared success.
ANJAC Health & Beauty, an industrial group with a turnover of c.€800m specializing in the formulation, manufacturing and filling of cosmetics, medical devices, drugs and food supplements, announced the completion of the acquisition of the Slovenian company Health Chain Group (HCG), a leading CDMO in the nutraceutical industry.
This acquisition is part of ANJAC broader strategy to strengthen its health and pharma activities, expanding its nutrition and innovative food ingredients offering. The goal is to bridge food and supplementation to provide unique health solutions that are always backed with clinical studies. The acquisition also enhances ANJAC’s commercial presence in high-potential markets across Central and Eastern Europe, as well as in Asia, the Middle East, and North America.
HCG, based in Ljubljana – Slovenia, is a leading international player in the food supplement market. It is a recognized nutraceutical expert thanks to its integrated model and a strong track-record on clinically supported turnkey solutions. Its fully integrated model – “Chain of Integrity” – allows the company to control the entire value chain from R&D to manufactured products.
Leveraging their experience in the Pharma & Healthcare sector, both Members were able to support ANJAC, marking a pivotal moment in the company’s journey.
